|
Evolved proteins lead to anti-HIV cyclic peptides
Novel Peptides Bind Elusive Therapeutic Target Critical to HIV Lifecycle Inventors - Brian McNaughton and David CrawfordAt a Glance McNaughton and Crawford have developed cyclic peptides with high affinity binding to the HIV-1 Trans-activation response (TAR) element RNA - a validated drug target comprising conserved, bulged stem-loop structures...
Published: 4/4/2019
|
Inventor(s): Brian Mcnaughton, David Crawford
Keywords(s):
Category(s): Biotechnology, Human Health
|
